IL6 and cancer: We also observed a trend toward higher serum concentrations of IL-6, a cancer-promoting cytokine, in some vehicle-treated mice (379.1pg/ml) compared to MRX2843-treated mice (45.4pg/ml, p=0.3) (Supplemental Figure 3A).